Literature DB >> 23165067

Stem cells. Could it be TIME to abandon BMCs?

Alexandra King.   

Abstract

Entities:  

Year:  2012        PMID： 23165067     DOI： 10.1038/nrcardio.2012.170

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  2 in total

1.  Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial.

Authors:  Jay H Traverse; Timothy D Henry; Carl J Pepine; James T Willerson; David X M Zhao; Stephen G Ellis; John R Forder; R David Anderson; Antonis K Hatzopoulos; Marc S Penn; Emerson C Perin; Jeffrey Chambers; Kenneth W Baran; Ganesh Raveendran; Charles Lambert; Amir Lerman; Daniel I Simon; Douglas E Vaughan; Dejian Lai; Adrian P Gee; Doris A Taylor; Christopher R Cogle; James D Thomas; Rachel E Olson; Sherry Bowman; Judy Francescon; Carrie Geither; Eileen Handberg; Casey Kappenman; Lynette Westbrook; Linda B Piller; Lara M Simpson; Sarah Baraniuk; Catalin Loghin; David Aguilar; Sara Richman; Claudia Zierold; Daniel B Spoon; Judy Bettencourt; Shelly L Sayre; Rachel W Vojvodic; Sonia I Skarlatos; David J Gordon; Ray F Ebert; Minjung Kwak; Lemuel A Moyé; Robert D Simari
Journal:  JAMA       Date:  2012-12-12       Impact factor: 56.272

2.  Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial.

Authors:  Joshua M Hare; Joel E Fishman; Gary Gerstenblith; Darcy L DiFede Velazquez; Juan P Zambrano; Viky Y Suncion; Melissa Tracy; Eduard Ghersin; Peter V Johnston; Jeffrey A Brinker; Elayne Breton; Janice Davis-Sproul; Ivonne H Schulman; John Byrnes; Adam M Mendizabal; Maureen H Lowery; Didier Rouy; Peter Altman; Cheryl Wong Po Foo; Phillip Ruiz; Alexandra Amador; Jose Da Silva; Ian K McNiece; Alan W Heldman; Richard George; Albert Lardo
Journal:  JAMA       Date:  2012-12-12       Impact factor: 56.272
  2 in total
  5 in total

1.  Controlling the structural and functional anisotropy of engineered cardiac tissues.

Authors:  W Bian; C P Jackman; N Bursac
Journal:  Biofabrication       Date:  2014-04-10       Impact factor: 9.954

2.  Detailed analysis of bone marrow from patients with ischemic heart disease and left ventricular dysfunction: BM CD34, CD11b, and clonogenic capacity as biomarkers for clinical outcomes.

Authors:  Christopher R Cogle; Elizabeth Wise; Amy M Meacham; Claudia Zierold; Jay H Traverse; Timothy D Henry; Emerson C Perin; James T Willerson; Stephen G Ellis; Marjorie Carlson; David X M Zhao; Roberto Bolli; John P Cooke; Saif Anwaruddin; Aruni Bhatnagar; Maria da Graca Cabreira-Hansen; Maria B Grant; Dejian Lai; Lem Moyé; Ray F Ebert; Rachel E Olson; Shelly L Sayre; Ivonne H Schulman; Raphael C Bosse; Edward W Scott; Robert D Simari; Carl J Pepine; Doris A Taylor
Journal:  Circ Res       Date:  2014-08-18       Impact factor: 17.367

Review 3.  Potential Strategies to Address the Major Clinical Barriers Facing Stem Cell Regenerative Therapy for Cardiovascular Disease: A Review.

Authors:  Patricia K Nguyen; Evgenios Neofytou; June-Wha Rhee; Joseph C Wu
Journal:  JAMA Cardiol       Date:  2016-11-01       Impact factor: 14.676

4.  A prospective, non-randomized, no placebo-controlled, phase Ib clinical trial to study the safety of the adipose derived stromal cells-stromal vascular fraction in idiopathic pulmonary fibrosis.

Authors:  Argyris Tzouvelekis; Vassilis Paspaliaris; George Koliakos; Paschalis Ntolios; Evangelos Bouros; Anastasia Oikonomou; Athanassios Zissimopoulos; Nikolaos Boussios; Brian Dardzinski; Dimitrios Gritzalis; Antonis Antoniadis; Marios Froudarakis; George Kolios; Demosthenes Bouros
Journal:  J Transl Med       Date:  2013-07-15       Impact factor: 5.531

Review 5.  The angiogenic properties of mesenchymal stem/stromal cells and their therapeutic potential.

Authors:  Suzanne M Watt; Francesca Gullo; Mark van der Garde; Daniel Markeson; Rosalba Camicia; Cheen P Khoo; Jaap Jan Zwaginga
Journal:  Br Med Bull       Date:  2013-10-23       Impact factor: 4.291
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.